• Press Release

BIA responds to the House of Lords Science and Technology Committee report on the Life Sciences Industrial Strategy

The House of Lords Science and Technology Committee have published its report on the Life Sciences Industrial Strategy. The BIA submitted written evidence to the inquiry last Autumn and BIA CEO Steve Bates also gave oral evidence to the Committee. Today the BIA has responded to the release of the report.

New CBI Report - Smooth Operations - Highlights Importance Of Getting EU Rules Right For Life Sciences

CBI seeks to inform Brexit negotiations by outlining where British businesses want to stay close to EU rules and where they want divergence.

BioIndustry Association/Informa Biotech Financing Update shows venture capital financing and follow on financing are off to a solid start in 2018

The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financings on the public markets are off to a solid start in 2018.

Statement in response to the EU Council ratifying the Brexit transition deal

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today responded to the European Council approving terms of the transition period agreed between the UK Government and EU.

BIA CEO Steve Bates responds to the transition period agreement for Brexit and negotiating guidelines for phase two

BIA CEO Steve Bates responds to the transition period agreement for Brexit and negotiating guidelines for phase two

Industry backs findings of new Health and Social Care Committee report into Brexit

Responding to a new House of Commons Health and Social Care Select Committee report ‘Brexit – Medicines, Medical Devices and Substances of Human Origin’, the trade associations representing the UK's pharmaceutical and biotech industries have issued a joint response backing the Committee's recommendations.

UK life science backs May's plan to remain part of EMA

BIA welcomes the Prime Minister’s announcement today that the UK will seek to explore with the EU, the terms on which the UK could remain part the European Medicines Agency, abide by the rules of the agency and make an appropriate financial contribution.

Brexit Health Alliance Campaign - The Impact of Brexit: Patient Access to Medical Research

Children could be excluded from lifesaving clinical trials for cancer treatments when the UK leaves the EU, according to the Brexit Health Alliance.

BIA launches new Genomics Advisory Committee at annual Committee Summit

Today the UK Bioindustry Association (BIA) launches its newest Advisory Committee, focused on the issue of genomics.

Harren Jhoti receives BIA Lifetime Achievement Award at Annual Gala Dinner

Harren Jhoti, co-founder of Astex and President and CEO of Astex Pharmaceuticals, was awarded the BioIndustry Association (BIA) Lifetime Achievement Award at the BIA’s annual Gala Dinner last night.